Literature DB >> 29929959

ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad.

Christophe Guignabert1,2, Frances de Man3, Marc Lombès2,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29929959     DOI： 10.1183/13993003.00848-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  12 in total

1.  Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: In silico study.

Authors:  Nitish Kumar; Atamjit Singh; Harmandeep Kaur Gulati; Kavita Bhagat; Komalpreet Kaur; Jaspreet Kaur; Shilpa Dudhal; Amit Duggal; Puja Gulati; Harbinder Singh; Jatinder Vir Singh; Preet Mohinder Singh Bedi
Journal:  Phytomed Plus       Date:  2021-06-06

Review 2.  In the eye of the storm: the right ventricle in COVID-19.

Authors:  John F Park; Somanshu Banerjee; Soban Umar
Journal:  Pulm Circ       Date:  2020-07-02       Impact factor: 3.017

3.  Stages or phenotypes? A critical look at COVID-19 pathophysiology.

Authors:  Amit Jain; D John Doyle
Journal:  Intensive Care Med       Date:  2020-05-18       Impact factor: 17.440

Review 4.  Let's talk about sex in the context of COVID-19.

Authors:  Luciane H Gargaglioni; Danuzia A Marques
Journal:  J Appl Physiol (1985)       Date:  2020-05-21

5.  The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients.

Authors:  Marco Vicenzi; Roberta Di Cosola; Massimiliano Ruscica; Angelo Ratti; Irene Rota; Federica Rota; Valentina Bollati; Stefano Aliberti; Francesco Blasi
Journal:  Eur Respir J       Date:  2020-05-19       Impact factor: 16.671

Review 6.  Pulmonary Artery Thrombosis: A Diagnosis That Strives for Its Independence.

Authors:  Olga Porembskaya; Yana Toropova; Vladimir Tomson; Kirill Lobastov; Leonid Laberko; Viacheslav Kravchuk; Sergey Saiganov; Alexander Brill
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

7.  Reply to the Comment by Dr. Cure on "Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade".

Authors:  Luca Perico; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nephron       Date:  2020-04-24       Impact factor: 2.847

8.  The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.

Authors:  I-Chen Chen; Jao-Yu Lin; Yi-Ching Liu; Chee-Yin Chai; Jwu-Lai Yeh; Jong-Hau Hsu; Bin-Nan Wu; Zen-Kong Dai
Journal:  Int J Med Sci       Date:  2020-09-16       Impact factor: 3.738

9.  Possible protective role of 17β-estradiol against COVID-19.

Authors:  Nabab Khan
Journal:  J Allergy Infect Dis       Date:  2020-08-19

Review 10.  Interplay of COVID-19 and cardiovascular diseases in Africa: an observational snapshot.

Authors:  Graham Chakafana; Daniel Mutithu; Julian Hoevelmann; Ntobeko Ntusi; Karen Sliwa
Journal:  Clin Res Cardiol       Date:  2020-08-18       Impact factor: 6.138
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.